Bertolani, A., Ravasio, R., Raimondo, P., & Jommi, C. (2022). The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study. Global and Regional Health Technology Assessment, 9(1), 73–81. https://doi.org/10.33393/grhta.2022.2415